Franklin Biolabs

Franklin Biolabs

生物技术研究

King of Prussia,Pennsylvania 1,224 位关注者

Providing comprehensive solutions from discovery to development & distribution for the global genetic medicines industry

关于我们

Franklin Biolabs, a new genetic medicines contract research organization (CRO), will be the services and production arm, providing comprehensive solutions from discovery to development and distribution for the global genetic medicines industry. Alongside GEMMABio, Franklin Biolabs will advance cell & gene therapy research and deliver therapeutics to patients around the world significantly faster.

网站
https://www.franklinbio.com/
所属行业
生物技术研究
规模
51-200 人
总部
King of Prussia,Pennsylvania
类型
私人持股
创立
2024
领域
Rare Disease 、RNA-seq、Single-cell analysis、indel analysis、Next generation sequencing、Manufacturing Process development、Preclinical vector production、Mass spectrometry、GMP manufacturing、Histology、Biodistribution、Toxicology Studies、Pharmacology Studies、B-Cell Assays、T-Cell Assays、In situ hybridization、electron microscopy、Fluorescence and brightfield microscopy、Analytics和Gene Therapy

地点

  • 主要

    411 Swedeland Rd

    US,Pennsylvania,King of Prussia,19406

    获取路线

Franklin Biolabs员工

动态

相似主页